TransCode Therapeutics, Inc. (RNAZ)
NASDAQ: RNAZ · Real-Time Price · USD
1.720
-0.050 (-2.82%)
Sep 23, 2026, 2:31 PM EDT - Market open
TransCode Therapeutics Market Cap
TransCode Therapeutics has a market cap or net worth of $29.12 million as of September 23, 2026. Its market cap has increased by 207.07% in one year.
Market Cap
29.12M
Enterprise Value
21.39M
1-Year Change
207.07%
Ranking
Category
Stock Price
$1.72
ChartMarket Cap Chart
Since the IPO on July 9, 2021, TransCode Therapeutics's market cap has decreased from $47.87M to $29.12M, a decrease of -39.16%. That is a compound annual growth rate of -9.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 29.12M | 364.97% |
| Dec 31, 2025 | 6.26M | 166.92% |
| Dec 31, 2024 | 2.35M | -43.27% |
| Dec 29, 2023 | 4.14M | -51.10% |
| Dec 30, 2022 | 8.46M | -73.50% |
| Dec 31, 2021 | 31.92M | -33.32% |
| Jul 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BeyondSpring | 30.83M |
| ABVC BioPharma | 30.07M |
| Quince Therapeutics | 29.98M |
| Quantum BioPharma | 29.60M |
| IGC Pharma | 29.46M |
| CEL-SCI | 29.20M |
| Kyntra Bio | 28.65M |
| NextCure | 28.01M |